v3.25.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Operating activities      
Net income $ 132,170 $ 100,118 $ 73,795
Adjustments:      
Depreciation of property and equipment 21,136 15,311 11,946
Stock-based compensation expense 24,953 22,785 22,460
Deferred income taxes 8,348 (5,257) (7,763)
Loss (gain) on debt and equity securities, net (24,620) (2,671) 823
Other 2,108 3,419 4,330
Changes in assets and liabilities, net of effects of acquisitions:      
Accounts receivable, net (8,779) (5,891) (7,833)
Income taxes, net (3,226) (2,418) 523
Other assets (4,542) (1,397) (2,143)
Accounts payable 907 359 664
Accrued expenses and other liabilities 12,939 (1,161) 3,937
Accrued revenue share 899 1,059 482
Deferred revenue 2,420 1,043 525
Net cash provided by operating activities 164,713 125,299 101,746
Investing activities      
Purchases of property and equipment (91,447) (52,535) (32,251)
Purchases of marketable securities (103,773) (86,679) (77,858)
Maturities and sales of marketable securities 83,240 103,428 86,672
Purchases of non-marketable securities (5,716) (5,034) (3,027)
Maturities and sales of non-marketable securities 1,367 882 947
Acquisitions, net of cash acquired, and purchases of intangible assets (1,592) (2,931) (495)
Other investing activities (2,370) (2,667) (1,051)
Net cash used in investing activities (120,291) (45,536) (27,063)
Financing activities      
Net payments related to stock-based award activities (14,167) (12,190) (9,837)
Repurchases of stock (45,709) (62,222) (61,504)
Dividend payments (10,049) (7,363) 0
Proceeds from issuance of debt, net of costs 64,564 13,589 10,790
Repayments of debt (32,427) (12,701) (11,550)
Proceeds from sale of interest in consolidated entities, net 400 1,154 8
Net cash used in financing activities (37,388) (79,733) (72,093)
Effect of exchange rate changes on cash and cash equivalents 208 (612) (421)
Net increase (decrease) in cash and cash equivalents 7,242 (582) 2,169
Cash and cash equivalents at beginning of period 23,466 24,048 21,879
Cash and cash equivalents at end of period 30,708 23,466 24,048
Supplemental disclosures of non-cash investing activities:      
Purchases of property and equipment included in accrued liabilities and accounts payable $ 15,090 $ 10,326 $ 7,435